CURE-ND4ALS seeks to remove the main scientific, technological, and clinical barriers that are still slowing down the development of efficient treatments for MND.
The initiative brings together the Paris Brain Institute, the DZNE (Deutsches Zentrum für Neurodegenerative Erkrankungen), Mission Lucidity (Leuven Brain Institute), and the UK Dementia Research Institute. The MND-SMART trial led by the Euan MacDonald Centre is a flagship project of the UK Dementia Research Institute.
CURE-ND4ALS was launched in Paris on 29th May.
One of the pillars of the initiative is to expand the MND-SMART clinical trial into Europe.
Read the full article on the Paris Brain Institute website: European CURE-ND alliance launches the CURE-ND4ALS initiative in order to speed up translational research into Charcot’s disease (ALS)
Related links
MND-SMART clinical trial website
MND-SMART project page on UK Dementia Research Institute website
Image credit: Paris Brain Institute
